The predictive tool is a boon for researchers studying how cells control the activity of genes, helping explain how cells achieve their key functions and how they go haywire, as happens in diseases such as cancer.
Jason Peters and colleagues have repurposed the gene-editing tool CRISPR to study which genes are targeted by particular antibiotics, providing clues on how to improve existing antibiotics or develop new ones.
Researchers discovered extraordinarily well preserved microfossils — mineralized ‘ghost cells’ — that closely resembled bacteria from the genus Staphylococcus.
Fred Blattner has been doing DNA research for more than 50 years, and he founded or co-founded three successful companies all focused on DNA: DNASTAR, Nimblegen and Scarab Genomics.
Jue “Jade” Wang, an associate professor of bacteriology at the University of Wisconsin–Madison, has been named a Howard Hughes Medical Institute (HHMI) Faculty Scholar.
Unlike many young biotech spinoffs, Fritz Schomburg's company — Lytic — earns its income not from federal research grants, but from shipping product.
Capitalizing on the ability of an organism to evolve in response to punishment from a hostile environment, scientists have coaxed the model bacterium Escherichia coli to dramatically resist ionizing radiation and, in the process, reveal the genetic mechanisms that make the feat possible.